Concomitantly, a recent study using liver-specific SHP1 KO mice showed that these mice were protected from obesity-induced severe NAFLD, which was possibly a result of reduced PPARγ promoting insulin resistance and hepatic inflammation [18]. This evidence concerns the gene PTPN6 and metabolic dysfunction-associated steatotic liver disease.